Stock Ideas 
News Letter Reviews Secret U.S. Gov't "Glitch" FDA Report Reviews
News Letter Reviews Secret U.S. Gov't "Glitch" FDA Report Reviews 
Market Watch
| The performance of the banking sector was decent during Q1FY08 with overall net profits growing 25-30%. | |
| More... |
Most Popular
Login Form
| Secret U.S. Gov't "Glitch" FDA Report Reviews |
| Monday, 07 April 2008 | ||||||||||
|
Earlier this year... the US Congress secretly launched an investigation, hiring the Breckinridge Institute -- a third-party think tank in Colorado – to assess the situation. Their report concluded: "The introduction of a new system will be delayed up to 5 years."In other words, there's nothing they can do to fix it anytime soon.Simply stated, this glitch is imbedded deep within one of the biggest, most important agencies of the U.S. government. It will take years and years (plus billions of dollars) to alter.In the meantime, we estimate you've got AT LEAST another 5 years to make the easiest, most extraordinary gains you've ever seen in the stock market. Dr. George Huang knows about this situation from first-hand experience. He's spent the better part of the past decade working in academic institutions, as a contractor with the U.S. government, and with private firms. In each position, he worked closely with this Federal Agency, and learned more about how the system works. Along the way, he figured out an extraordinary way to make money. I assure you, we've done an incredible amount of legwork on this situation. Dr. Huang has crisscrossed the country 5 times in the past year to check it out. And we've had our in-house counsel review the entire process with a fine-tooth comb. So how does this government glitch work, exactly?This "glitch" manifests itself in the form of a one-page letter – faxed from Federal Government building No. 33 in Silver Spring, Maryland...And sent to certain publicly traded US companies This 6-story office building houses the Food and Drug Administration – commonly known as the FDA. Everyone American knows about the FDA... to some extent.
They give final approval on nearly all new medical treatments in the US. Of course, they give final approval of prescription drugs such as Lipitor and Celebrex. But that's just one small part of what the FDA does. In short, the FDA has an incredible backlog of products, treatments, and new drugs to review. They're understaffed. And, like most bloated bureaucracies, they are incredibly inefficient. But unlike most government red tape, the FDA's bureaucratic mess can actually work in your favor as an investor. In short, it can help you make incredibly large profits, safely... in a relatively short period of time. So for the next few days, we're offering you first crack – the chance to get in before the official commercial launch of the FDA REPORT. For much less (50% - 100%) than what the general public will have to pay. Excerpted :DailyWealth This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
||||||||||
Reviews (2)
| < Prev | Next > |
|---|
